Stocks and Investing
Stocks and Investing
Thu, May 14, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, May 13, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Nierengarten Maintained (SWTX) at Buy with Increased Target to $48 on, May 13th, 2020
David Nierengarten of Wedbush, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $45 to $48 on, May 13th, 2020.
David has made no other calls on SWTX in the last 4 months.
There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $58 on, Tuesday, April 14th, 2020
- Raghuram Selvaraju of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $60 on, Thursday, March 19th, 2020
Contributing Sources